Announcements Trials

Browse Landscape

Phase

Phase 2 17 Phase 1 6 Phase 1/2 4 Phase NA 2 Phase 2/3 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 46 Thoracic 34 Breast 28 Gynecologic 20 Head & Neck 17 Other hematologic neoplasm 13 Lymphoid 13 Genitourinary 9 CNS 4 Tumor-Agnostic 3 Plasma cell 2 Other solid neoplasm 2 Dermatologic 2 Sarcoma 1 Myeloid 1

Conditions

Interventions

Doxorubicin 40 Radiotherapy 30 Ifosfamide 28 Vincristine 27 Cyclophosphamide 24 Imatinib Mesylate 20 Etoposide 20 Dactinomycin 14 Radiation 13 Filgrastim 11 Temozolomide 9 Sunitinib 9 Trabectedin 8 Methotrexate 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 6 Granulocyte Colony-Stimulating Factor 6 Chemotherapy, Adjuvant 6 pazopanib 5 nilotinib 5 Zoledronic Acid 5 Neoadjuvant Therapy 5 Irinotecan 5 Cisplatin 5 Carboplatin 5 X-Rays 4 Vinorelbine 4 Topotecan 4 Surgical Procedures, Operative 4 Procarbazine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Drug Therapy × Sarcoma × Clear all

NCT04307277 2026-04-14

CHIC-STS01

Institut Claudius Regaud

Phase 3 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡